| Completed |
: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)
: T-cell-prolymphocytic Leukemia
: 2010-08-20
: - Drug: Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
|
| Terminated |
: Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia
: Prolymphocytic Leukemia
: 2006-01-24
: - Biological: rituximab
- Drug: cyclophosphami
|
| Completed |
: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
: Prolymphocytic Leukemia
: 2006-01-16
: - Biological: alemtuzumab
- Drug: cyclophospha
|
| Terminated |
: Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
: - B-cell Chronic Lymphocytic Leukemia
- Prolymphocytic Leukemia
: 2004-12-07
: Drug: alvocidib Other Names:
|
| Completed |
: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
: - B-cell Chronic Lymphocytic Leukemia
- Hematopoietic/Lymphoid Cancer
-
- Drug: carfilzomib Given IV inf
|
| Terminated |
: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia
: - Leukemia, Lymphoma, Chronic Lymphocytic
- Leukemia, Prolymphocytic
: 2007-12-21
: - Drug: CAT-8015 5 mcg/kg Partic
|
| Terminated |
: 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
: - B-cell Chronic Lymphocytic Leukemia
- Prolymphocytic Leukemia
: 2004-12-07
: - Drug: tanespimycin Given IV
|
| Withdrawn |
: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia
: - Leukemia
- Acute Lymphocytic Leukemia
: 2010-07-12
: Drug: Velcade IV Other Name: Bortezomib
|
| Completed |
: Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)
: Leukemia, Lymphocytic, Chronic
: 2007-04-20
: Drug: alvocidib 1st dose: 30 mg/m2 as a 30-minute intraven
|
| Withdrawn |
: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation
: - Prolymphocytic Leukemia
- Recurrent Mantle Cell Lymphoma
: 2014-11-04
: - Drug: sotrastaurin acetate Giv
|
